NTRA Natera, Inc. $19.20B $140.63 BIIB Biogen Inc. $17.98B $122.68 ILMN Illumina, Inc. $15.01B $94.80 INCY Incyte Corporation $13.04B $67.38 MRNA Moderna, Inc. $11.98B $30.97 TEM Tempus AI, Inc. $9.75B $58.01 GH Guardant Health, Inc. $5.65B $45.64 TWST Twist Bioscience Corporation $2.08B $34.77 ADPT Adaptive Biotechnologies Corporation $1.57B $10.31 TXG 10x Genomics, Inc. $1.44B $11.54 NTLA Intellia Therapeutics, Inc. $1.31B $12.63 GRAL GRAIL, Inc. $1.24B $34.35 MAZE Maze Therapeutics, Inc. $729.66M $16.66 DNA Ginkgo Bioworks Holdings, Inc. $662.58M $11.32 RLAY Relay Therapeutics, Inc. $622.35M $3.63 PSNL Personalis, Inc. $547.62M $6.20 FLGT Fulgent Genetics, Inc. $540.37M $17.75 PGEN Precigen, Inc. $540.18M $1.83 PACB Pacific Biosciences of California, Inc. $435.12M $1.45 MYGN Myriad Genetics, Inc. $410.19M $4.45 ARCT Arcturus Therapeutics Holdings Inc. $373.99M $13.79 FHTX Foghorn Therapeutics Inc. $340.02M $6.10 DSGN Design Therapeutics, Inc. $229.91M $4.05 NEO NeoGenomics, Inc. $159.84M $6.21 MGX Metagenomi, Inc. Common Stock $81.12M $2.17 PEPG PepGen Inc. $43.19M $1.32 CAMP CAMP4 Therapeutics Corporation $32.06M $1.59 BNGO Bionano Genomics, Inc. $11.74M $3.49